Pharmacotherapy of CSA: who, when and how? Source: Sleep and Breathing Conference 2021 Year: 2021
Long-term oral antibiotic treatment: why, what, when and to whom? Source: Eur Respir Monogr 2017; 75: 185-205 Year: 2017
Practical approach to the difficult-to-wean patient: who, how and where? Source: ERS Skills Course 2016 Year: 2016
Positional therapy: easy and effective? Source: Sleep and Breathing Conference 2017 Year: 2017
Clustering in asthma: why, how and for how long? Source: Eur Respir J 2013; 41: 1247-1248 Year: 2013
Medical therapy of sarcoidosis: who to treat and how? Source: Annual Congress 2012 - PG8 State-of-the-art management of sarcoidosis Year: 2012
Perspective of a pulmonologist: what might we expect and what do we need to know? Source: Eur Respir Monogr 2015; 68: 261-273 Year: 2015
Initial outpatient management of PE: who and how? Source: International Congress 2018 – Pulmonary embolism: what we need to know Year: 2018
Immunotherapy: when, who and which drug? Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018
The goal is to go further and do better: but how? Source: Eur Respir Rev 2015; 25: 1-3 Year: 2016
Optimising bronchodilator therapy in COPD: Who, why and when? Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care Year: 2019
Identifying the unmet needs in asthma: Who, why and how many? Source: International Congress 2014 – Identifying the unmet needs in asthma: Who, why and how many? Year: 2014
The sustainability agenda and inhaled therapy: what do patients want? Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021
TB vaccination: why, when, how and what? Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014